Inventor
ZENG QINGBEI
US26 patents
⚠️ This page may combine multiple inventors who share the name “ZENG QINGBEI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
9 patentsUS7417045B2Aug 26, 2008
Heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity
SCHERING CORP64 citations97
US7220735B2May 22, 2007
Benzimidazolone histamine H3 antagonists
SCHERING CORP31 citations92
US7105505B2Sep 12, 2006
Benzimidazole derivatives useful as histamine H3 antagonists
SCHERING CORP27 citations92
US6849621B2Feb 1, 2005
Piperidine compounds
SCHERING CORP39 citations92
US7799789B2Sep 21, 2010
Heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity
SCHERING CORP10 citations84
US7868005B2Jan 11, 2011
Pyrazinyl substituted piperazine-piperidines with CXCR3 antagonist activity
SCHERING CORP9 citations83
US7879838B2Feb 1, 2011
Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity
SCHERING CORP10 citations82
US7868006B2Jan 11, 2011
Heterocyclic substituted piperazines with CXCR3 antagonist activity
SCHERING CORP3 citations62
US7238688B2Jul 3, 2007
Piperidine compounds
SCHERING CORP1 citations51
DIZAL JIANGSU PHARMACEUTICAL CO LTD
6 patentsUS10822334B2Nov 3, 2020
ErbB receptor inhibitors
DIZAL JIANGSU PHARMACEUTICAL CO LTD4 citations71
US11447492B2Sep 20, 2022
ERBB receptor inhibitors
DIZAL JIANGSU PHARMACEUTICAL CO LTD0 citations61
US11629147B2Apr 18, 2023
Triazolo-pyrimidine compounds and uses thereof
DIZAL JIANGSU PHARMACEUTICAL CO LTD0 citations60
US11571420B2Feb 7, 2023
Pyrazine compounds and uses thereof
DIZAL JIANGSU PHARMACEUTICAL CO LTD0 citations60
US10898481B2Jan 26, 2021
Pyrazine compounds and uses thereof
DIZAL JIANGSU PHARMACEUTICAL CO LTD1 citations60
US10858365B2Dec 8, 2020
Triazolo-pyrimidine compounds and uses thereof
DIZAL JIANGSU PHARMACEUTICAL CO LTD1 citations60
ASTRAZENECA AB
3 patentsUS9375432B2Jun 28, 2016
Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor
ASTRAZENECA AB1 citations60
US9066979B2Jun 30, 2015
Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor
ASTRAZENECA AB3 citations60
US9718806B2Aug 1, 2017
Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor
ASTRAZENECA AB0 citations50